JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Search results for: 'research area pi3k akt signaling pi3k inhibitors'

A4200 Apogossypolone (ApoG2)

2 Citation

Target: Bcl-2|Bcl-xl|Mcl-1

Summary: Bcl-2 inhibitor,nonpeptidic small molecule

≥24.55 mg/mL
A8364 ARN-509

2 Citation

Target: Androgen Receptor

Summary: Androgen receptor inhibitor

≥23.85 mg/mL
B1119 Efavirenz

Target: HIV-1 reverse transcriptase

Summary: Reverse transcriptase inhibitor

insoluble in H2O; ≥15.55 mg/mL
B2114 Mitoxantrone HCl

Target: Pim|Topoisomerases|USP|HIV Integrases

Summary: Topoisomerase II inhibitor, anti-neoplastic drug

insoluble in EtOH; ≥51.53 mg/mL
A4221 YM155

2 Citation

Target: Survivin

Summary: Survivin suppressant,apoptosis inhibitor

≥22.15 mg/mL
A4065 PF-04929113 (SNX-5422)

Target: HSP90

Summary: Hsp90 inhibitor,potent and selective

≥23.85 mg/mL
A8178 Panobinostat (LBH589)

10 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
B2266 LDE225 (NVP-LDE225,Erismodegib)

1 Citation

Target: Smoothened

Summary: Smoothened inhibitor,potent and selective

≥24.3 mg/mL
A2133 Saracatinib (AZD0530)

3 Citation

Target: Src

Summary: Src/Abl inhibitor,potent and selective

≥27.1 mg/mL
A4096 Belinostat (PXD101)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL